Assessing the impact of radiation dose exposure to lung and heart on effort tolerance

MAHE Manipal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•Patients being planned for definitive or adjuvant thoracic radiotherapy that involves direct radiation exposure to at least a part of heart and lungs.
•2. Good performance score (KPS >=70), and ability to perform the physical tests required for assessment.
•3. Adequate baseline hematocrit, and cardiac and pulmonary function. Estimated life expectancy of at least 12 months.
•4. Willing to participate in the study, and provides voluntary informed consent

•1.KPS <70.
•2.Patients being treated with extreme hypofractionated regimen, mainly SBRT.
•3.Other comorbidities such as Chronic Lung disease, cardiac disease, anemia at presentation, chronic kidney disease, peripheral neuropathy, disabilities in ambulation, etc., that might interfere with the conduct of the physical assessments.
•4.Baseline impairment in respiratory or cardiac function as an indirect result of the tumor; eg. Lobar/pulmonary collapse secondary to obstructing tumor, pleural or pericardial effusion, etc.

发起方

MAHE Manipal